KR20150134740A - Anti-aging, Anti-inflammatory and Skin-Astriction composition for skin external application comprising Artemisia annua L. Cell Culture Extract and Methods for preparing the Same - Google Patents

Abstract

The present invention relates to a composition for skin external application having anti-inflammatory, skin-astriction, and anti-aging effects containing Artemisia annua L. plant cell culture extract, and a method for preparing the same and, more specifically, to a composition for skin external application having anti-inflammatory, skin-astriction, and anti-aging effects containing a plant cell culture or an adventitious root culture, derived from Artemisia annua L. plant body which is one of rare plant species, or an extract thereof, and to a method for preparing the same. According to the present invention, the composition for skin external application containing a plant cell or adventitious root culture, or an extract thereof has no toxicity to skin cells and provides anti-aging effects including skin astriction, whitening, anti-inflammation, and wound healing, and the like.

Description

TECHNICAL FIELD The present invention relates to a composition for external application for skin having anti-inflammatory, astringent, anti-aging effect and an anti-aging, anti-inflammatory and skin-astriction composition for skin cell culture extract containing Artemisia annua L. Cell Culture Extract and Methods for Preparing the Same}

The present invention relates to the use of Artemisia The present invention relates to a composition for external application for skin having anti-inflammatory, astringent and anti-aging effects containing plant cell culture extracts and a method for preparing the same, and more particularly to a plant cell culture derived from a rare plant Leaf mugwort plant, Skin aging, anti-aging skin composition containing water or an extract thereof, and a method for producing the same.

Over time, the secretion of various hormones that regulate metabolism is reduced, and the function of immune cells and the activity of cells are lowered, so that the biosynthesis of immune proteins and biologic proteins necessary for the living body is reduced The skin becomes thinner (in the case of endogenous aging) and the elasticity is decreased by intrinsic aging which is caused by external aging and photoaging due to various pollutants and ultraviolet ray externally, Keratinocytes and melanocytes are damaged by UVB. Skin aging is divided into chronologic aging, which occurs in areas that are not exposed to sunlight, and actinic aging, which is a combination of chronologic aging and degenerative changes in the exposed parts of sunlight. In chronological aging, characteristic clinical signs of skin are fine wrinkles, atrophy of dermis, and decrease of subcutaneous fat layer. In the photoaging process, coatse wrinkling and furrowing appear and abnormal elasticity material accumulates and the skin thickens and loosens like leather. The phenomenon seen in chronic sunlight-damaged skin is an abnormal increase in the elastic elastosis and proteoglycan of the upper collagen of the dermis and a significant decrease in collagen, the main protein of the dermis. Collagen gives strength and tension to the skin, which protects the skin from external stimuli or forces, and it accounts for 90% of the dermis. Collagen reduction is closely related to skin and aging. In cells, cellular activity decreases due to endogenous senescence and photoaging, signal transduction system becomes incomplete, biosynthesis of matrix metalloproteinases (MMPs), which degrade skin tissues, is increased, collagen biosynthesis is reduced and wrinkles are formed and elasticity , And it is known that melanogenesis leading to skin blackening is increased. Therefore, it can inhibit the biosynthesis of MMPs that decompose collagen, which is a substrate substance constituting the skin, substances that can thicken the skin by proliferating skin cells or increasing the matrix substances constituting the skin, inhibiting melanin biosynthesis And the like are found to alleviate skin symptoms such as wrinkles, loss of elasticity, and skin blackening.

Although researches on whitening, anti-aging and anti-inflammatory substances have been actively conducted, existing chemical substances are limited in their use due to various problems such as toxicity, low activity, limitations of application and side effects due to excessive use In order to develop a material with low potential for side effects, active ingredient extraction in natural plants has been actively studied. However, even in the case of natural products, there are many problems in using cosmetics or medicines at an effective concentration or more in terms of safety, stability, and discoloration possibility.

On the other hand, Artemisia annua as a rare plant is also called dog mugwort or dog mugwort. It grows on a road, a pavilion, and a river. It is about 1m in height. There is no hairs on the whole grass, it has a peculiar smell. The flower blooms in June-September with greenish-yellow color, and the small headstock runs like a spike, and the whole flower is conical. The fruit is an achene with a length of about 0.7mm.

In recent years, many studies have been made on the development of functional foods using botanical resources and the utilization of them as cosmetic materials. However, regarding the mugwort mugwort, prior art (Patent Document 1) using mugwort mugwort extract for removing bad breath, (Patent Document 2), there is no research as a cosmetic material for the plant cell, the adventitious root culture or the extract thereof cultured therefrom.

Patent Document 1: Korean Patent No. 10-1102476 Patent Document 2: Korean Patent No. 10-0930839

The inventors of the present invention have confirmed that plant cells, adventitious roots or extracts thereof have an effect on anti-inflammation, anti-aging, skin convergence and whitening including wound healing, and completed the present invention.

It is therefore an object of the present invention janip mugwort (Artemisia The present invention also provides a composition for external application for skin for improving skin comprising plant cells, adventitious roots or annua plant extract or its extract as an active ingredient.

In the present invention, the skin improving agent means improvement of the skin condition, and includes, for example, skin whitening and whitening.

Another object of the present invention is to provide a process for the production of Artemisia annua of plant cell, adventitious root culture or extract thereof as an active ingredient.

A further object of the present invention is to provide a method for the production of Artemisia annua of plant cell, adventitious root culture or extract thereof as an active ingredient.

It is still another object of the present invention to provide a method for preparing a skin external application composition for skin improvement, anti-inflammation or wound healing, which comprises the plant cell of Mugwort wormwood, the culture of adventitious roots or the extract thereof as an active ingredient.

In order to achieve the above object, the present invention janip mugwort (Artemisia annua L. ) plant cells, adventitious roots cultures or extracts thereof as an active ingredient.

The invention also janip mugwort (Artemisia annua L. ) plant cells, adventitious roots cultures or extracts thereof as an active ingredient.

The invention also janip mugwort (Artemisia annua L. ) plant cell, adventitious root culture or an extract thereof as an active ingredient.

The invention also janip mugwort (Artemisia annua L. ) plant cell, adventitious root culture or extract thereof as an active ingredient.

The invention also janip mugwort (Artemisia annua L. ) plant cells, adventitious roots cultures or extracts thereof as an active ingredient.

The present invention also relates to a process for the production of Artemisia sp. annua L. ) plant cell, adventitious root culture or extract thereof, which comprises: a) preparing a composition for external application for skin improvement, anti-inflammation or wound healing,

(a) separating leaves or stem tissues of the mugwort plant and culturing them into plant cells or adventitious roots; And (b) preparing a composition for external application for skin containing the cultured plant cell of Mugwort mugwort or an adventitious root culture or an extract thereof.

The composition according to the present invention for mugwort plant cell or adventitious root culture or the composition for external application for skin containing the extract has no skin toxicity, whitening, whitening, anti-inflammation, and wound healing efficacy.

FIG. 1 is a diagram showing the process of inducing plant cells from the mugwort plant.
Fig. 2 is a graph showing the results of HPLC analysis of plant cell culture extracts derived from the mugwort plant.
FIGS. 3 and 4 are experimental results showing an increase in expression of COX-2 and iNOS.
Fig. 5 is an experimental result for confirming the wound healing function of the plant cell culture extracts derived from the residual wormwood plant.
FIG. 6 is a graph showing the healing area in order to confirm the wound healing function of the plant cell culture extracts derived from the mugwort plant.

The present invention relates to the use of Artemisia annua L. ) or an extract thereof, as an active ingredient, and a method for producing the composition.

The invention in one aspect, janip mugwort (Artemisia annua L. ) or an extract thereof, as an active ingredient, to a skin external composition for skin improvement.

In the present invention, the term "for skin improvement" is intended to include improvements in the condition of the skin such as skin convergence, antiaging, skin wrinkle improvement, skin elasticity enhancement, skin barrier function protection or enhancement.

In the present invention, the expression "comprising as an active ingredient" means that the composition for external application for skin contains an effective amount of such a degree as exhibiting various skin improving effects, whitening, skin convergence, antiinflammatory, do.

In the present invention, the cultivated plant mugwort plant cell of the residual leaf mugwort is obtained by cultivating a part or all of the stem, petal, roots and leaves of the mugwort plant, for example, by cutting in an induction medium.

Such culture induction is related to plant tissue culture, and plant tissue culture is a technique for cultivating asphyxiated small plant tissue in vitro to grow plant cells, organs and plants according to the purpose of culture. Plant tissue culture can be attributed to the basic characteristics of plants. Plant tissue culture technology is based on the use of differentiating totipotency to regenerate plants from plant somatic cells, a unique feature of plants. Namely, plants can be regenerated from these cells and tissues by culturing single cells (including protoplasts), leaves and root sections of plants in a medium supplemented with specific nutrients and growth regulators. The ability of these plants to have differentiating totipotency is a strategy for survival from harsh environments and herbivorous damage for the fixation and long-term survival of plants. Therefore, plants can be said to have the ability to regenerate lost organs again. The plant tissue cells isolated from the parent plant have the potential to be reproduced as a complete plant when cultured in a suitable culture environment, that is, plants having typical performance are of academic importance such as embryology, but they are also utilized for practical use of cosmetic raw materials .

"Plant cell culture" refers to a specific tissue or cell mass produced when a tissue cut out from a plant is cultured in a medium containing an auxin, a wound is injured to a certain kind of plant, or an auxin is treated with the excipient. Usually callus is an amorphous tissue or cell mass that has lost its ability to cause normal organogenesis or tissue differentiation, and is mostly flowcytosed. In a broad sense, it also includes plant tumor tissue caused by infection such as agrobacterium.

Therefore, it is possible to induce any part derived from any part of the stem or leaf of the mugwort of the present invention. However, in one embodiment, the stem of the mugwort and the part of the leaf of the mugwort or the cotyledon of the mugwort seed, , And plant cells may be formed by cutting off some of the leaves of mugwort, and then placing the auxin and cytokinin in a controlled medium. In the case of adventitious root cultivation, the same process as that of plant cell cultivation is carried out, but the combination of plant hormones is different so that the adventitious roots can be induced. For example, when the plant hormone contained in the induction medium is a plant cell culture, a combination of p-chlorophenoxyacetic acid and kinetin, or in the case of adventitious roots, p-chlorophenoxyacetic acid and zeatin are contained Induction culture.

In the present invention, the plant cell or adventitious root culture or the extract thereof of the mugwort can be contained in an amount of 0.1 to 10% by weight based on the total weight of the composition.

These ratios are merely preferable ranges. For example, in the following examples, 1 wt% or 2 wt% of the test results are included. However, it is confirmed that 5% and 10% Survival rate was also not affected by 10%. It is also apparent to those skilled in the art that, in addition to the above, 20% and 30% or more of the skin have excellent skin improving effect, skin convergence, anti-inflammation, and wound healing function.

In the present invention, the skin improving agent includes skin whitening agents and whitening agents.

In the present invention, the plant cell or the adventitious root culture (cultured product) itself of the mugwort or the cultured material is used by filtration, the culture is crushed or used, or the culture is dried to be powdered, .

In the present invention, "extract" means an extract obtained by powdering the plant cell or adventitious root culture extract of the mugwort, or by various known extraction methods such as cold water extraction method, hot water extraction method, ethanol and jojoba oil extraction method.

The extraction method in the present invention is not particularly limited, and examples thereof include cold extraction, ultrasonic extraction, reflux extraction, hot water extraction, and jojoba oil extraction. Here, in the case of hot water extraction, hot water extract is obtained by heating at 80 to 100 ° C for 8 to 48 hours in a hot water distiller.

In the case of cold water extraction, for example, cold water (15 to 25 ° C) is mixed with the culture itself or the dried powder thereof and extracted for 3 days to obtain a cold water extract.

Alternatively, it can be produced by a method of extracting using water, an organic solvent, or a mixed solvent thereof. The extracted liquid can be used directly or by concentrating and / or drying. In the case of extraction using an organic solvent, an organic solvent such as methanol, ethanol, isopropanol, butanol, ethylene, acetone, hexane, ether, chloroform, ethyl acetate, butyl acetate, dichloromethane, N, (DMSO), 1,3-butylene glycol, propylene glycol, or a mixed solvent thereof. The active ingredient of the herbal medicine may be extracted at room temperature or warmed under the condition that the active ingredient is not destroyed or minimized. Depending on the organic solvent to be extracted, the degree of extraction and the degree of loss of the active ingredient of the medicament may differ. Therefore, an appropriate organic solvent should be selected and used. Particularly, in the present invention, an ethanol extract, preferably a 20-50% ethanol extract, specifically 50% ethanol extract, is preferable. As described in the examples, the extract is mixed with 50% ≪ / RTI >

In the present invention, the above extract may be used by concentration or dilution, and a distillate of the extract may be used.

The invention from another point of view, janip mugwort (Artemisia annua L. ) plant cell, adventitious root culture or extract thereof, which comprises: a) preparing a composition for external application for skin improvement, anti-inflammation or wound healing,

(a) separating leaves or stem tissues of the mugwort plant and culturing them into plant cells or adventitious roots; And

(b) preparing a composition for external application for skin containing the cultured plant cell of Mugwort mugwort or a culture of adventitious roots or an extract thereof.

The step (a) is a step of obtaining a plant tissue culture, that is, a plant cell culture, or an adventitious root culture, with some tissue isolated from the mugwort plant.

In the present invention, leaves, stems, petals, or roots of the mugwort plant may be separated and used.

In the present invention, a suitable medium may be selected for deriving the plant cell culture or the adventitious root culture from the separated tissue. In the step (a), a suitable medium may be selected to cultivate the mugwort plant cell or the adventitious root. If there is a medium commonly used in plant tissue culture in the technical field, it can be used without limitation. For example, the composition of the MS medium (1 L standard) is 1650 mg NH ₄ NO ₃ , 1900 mg KNO ₃ , 440 mg CaCl ₂ .2H ₂ O, MgSO 4, _{4 .7H 2 O 370 mg, KH} 2 PO 4 170 mg, KI 0.83 mg, H 3 BO 3 6.2 mg, MnSO 4 .4H 2 O 22.3 mg, ZnSO 4 .7H2O 8.6 mg, Na 2 MoO 4 .2H 2 O 0.25 mg, CuSO ₄ , 5H ₂ O 0.025 mg, CoCl ₂ .6H ₂ O 0.025 mg, FeSO ₄ .7H ₂ O 27.8 mg, Na ₂ EDTA.2H ₂ O 37.3 mg, Myoinositol 100 mg, Nicotinic acid 0.5 mg, Pyridoxine -HCl 0.5 mg, Thiamine-HCl 0.5 mg, Glycine 2 mg, and Sucrose 30000 mg.

There is almost no difference in the basic MS medium composition when inducing plant cell culture from plant leaves, plant stem, and plant petal, but the kinds of plant growth hormone that are most important in inducing plant cells and adventitious roots are different.

In the case of the plant cell culture according to the present invention, in the case of plant cell culture derived from a leaf or a stem, a plant cell culture can be obtained by culturing in the presence of p-chlorophenoxyacetic acid and kinetin have.

The combination ratio of each hormone is preferably 1: 0.01 to 0.1, or 1: 0.03 to 0.07 for p-chlorophenoxyacetic acid and kinetin.

On the other hand, in the case of adventitious root culture, the adriamycin culture can be obtained by culturing it in the medium containing p-chlorophenoxyacetic acid and zeatin.

The combination ratio of the respective hormones may be in the range of 1: 0.01 to 0.1, or 1: 0.03 to 0.07 for p-chlorophenoxyacetic acid and zeatin.

In the present invention, it may include additional steps for increasing the efficacy of anti-inflammation, wound healing, whitening, and skin convergence. Such additional treatments include four-photoperiod, UVA treatment, jasmonic acid, It is also possible to increase the content of phenolic compounds, carotenoids and flavonoids in the culture through this treatment.

In the present invention, the additional treatment step may include a step of irradiating light with a period of 9 hours to 15 hours / 15 hours to 9 hours, or UVA treatment for 3 to 6 hours, , ≪ / RTI > citric acid or jasmonic acid to the 150 mu M to 400 mu M medium.

As an example,

(One). Photoperiod: Cultured at 3 hours / 21 hours, 6 hours / 18 hours and 12 hours / 12 hours (day / cancer) on a growth regulated at 30 molm ^-2 s ^-1 light intensity every day.

(2). UVA: A UV-A fluorescent lamp (20 W, Sankyo Denki, Japan), a physical attractant, is cultured for 0.5 to 8 hours each day.

(3). Shikimic acid: 200 ~ 600 μM Shikimic acid is cultured in MS medium.

(4). Jasmon acid: 100 ~ 500 μM Jasmonic acid is cultured in MS medium.

- Optical processing -

To MS basal medium p-Chlorophenoxyacetic acid (4-CPA ) 2 mg / L, Kinetin was added to growth regulator of 0.1 mg 25 ℃ culture temperature and 30 molm ^-2 s ^-1 Gwangju group on a control growth to zero light intensity Hour / 24 hours, 3 hours / 12 hours, 6 hours / 18 hours, 12 hours / 12 hours and then cultured for 8 weeks.

- The physical attractant, UV-A -

MS medium supplemented with 2 mg / L of p-chlorophenoxyacetic acid (4-CPA) and 0.1 mg of kinetin were added for 5 weeks at a culture temperature of 25 ° C. After 6 weeks of culture, a UV-A fluorescent lamp , Sankyo Denki, Japan) at 0, 0.5, 2, 4 and 8 hours daily.

- Shikimic acid treatment -

MS medium supplemented with 2 mg / L of p-chlorophenoxyacetic acid (4-CPA) and 0.1 mg of kinetin were added and cultured at 25 ℃ for 5 weeks. Sikimic acid was added to the medium at the concentration of 50, 100, 250 and 500 μM on the sixth week of culture, and cultured.

- Treatment of Jasmonic acid -

    Jasmonate and methyl jasmonate, which are involved in the expression of plant defense mechanisms, are involved in plant growth, development, aging of leaves and defense mechanisms of whole plants as well as increase of physiologically active substances in plants. MS medium supplemented with 2 mg / L of p-chlorophenoxyacetic acid (4-CPA) and 0.1 mg of kinetin were added and cultured at 25 ℃ for 5 weeks. Jasmonic acid is added to the medium at the concentration of 100, 250 and 500 μM on the sixth week of culture, and cultured.

In the present invention, it is preferable that in the step (b), the composition containing the plant cell or the adventitious root culture obtained as a result of the cultivation in the step (a) is prepared from a suitable external preparation for skin composition, And can be prepared in the form of an external preparation for skin in a suitable form.

For example, in step (b), the plant cells or adventitious roots of the mugwort plant obtained in step (a) are dried, powdered and mixed with purified water to prepare a composition,

the plant cells or adventitious root cultures of the mugwort plant obtained in step (a) are dried, powdered and mixed with purified water, and then extracted with cold water, hot water, jojoba oil, vegetable oil, And extracting with an organic solvent such as ethanol or the like to prepare a composition.

As another example, the culture obtained in the step (a) may be dried by hot air and powdered to evaporate water.

In the present invention, the principle of skin astringent action is a phenomenon in which skin is contracted by binding with polymer flavonoids of skin protein to form crosslinks. Convergence means basically wrinkled or funky. Convergent agent has a function to shrink skin and mucosal blood vessels, and has an effect of inhibiting secretion of mucus by interrupting cell gap and lymphatic gap. In addition, since astringent agent has a property of binding to protein, it can generally judge degree of convergence effect according to degree of binding of hemoglobin protein to extract. Such convergent action may be said to have an effect of forming an insoluble film on the surface of the skin and mucous membranes by external application or contents and consequently protecting the locality or densifying the tissue to reduce the permeability of the cell membrane.

Also, the mugwort plant cell, amygdalus culture or its extract according to the present invention has excellent melanogenesis inhibiting ability and can be used for whitening.

Also, the mugwort plant cell, the adventitious root culture or its extract according to the present invention promotes the proliferation and migration of keratinocytes, and has wound healing and anti-aging effect.

Also, the mugwort plant cell, the adventitious root culture or the extract thereof according to the present invention has an anti-inflammatory effect through inhibition of COX-2 and iNOS activity.

In the present invention, the composition for external application for skin may be a cosmetic composition or a pharmaceutical composition.

The cosmetic composition of the present invention may contain an acceptable carrier in cosmetic preparations. Herein, "an acceptable carrier for a cosmetic preparation" is a known or used compound or composition that can be contained in a cosmetic preparation, or a compound or composition to be developed in the future, which is toxic, instable or irritating It says nothing.

The carrier may be included in the skin topical composition of the present invention in an amount of from about 1% by weight to about 99.99% by weight, preferably from about 90% by weight to about 99.99% by weight of the composition, based on the total weight thereof. However, since the ratio varies depending on the formulations described below in which the composition for external application for skin of the present invention is prepared, and its specific application site (face, neck, etc.) or its preferable application amount and the like, And should not be construed as limiting the scope of the invention.

Examples of the carrier include an alcohol, an oil, a surfactant, a fatty acid, a silicone oil, a wetting agent, a moisturizer, a viscous modifier, an emulsifier, a stabilizer, an ultraviolet scattering agent, an ultraviolet absorber, a coloring agent and a perfume. The compounds / compositions which can be used as the above-mentioned alcohol, oil, surfactant, fatty acid, silicone oil, humectant, humectant, viscous modifier, emulsifier, stabilizer, ultraviolet scattering agent, ultraviolet absorber, The person skilled in the art can select and use the appropriate substance / composition.

In an embodiment of the present invention, the composition for external application for skin according to the present invention may contain at least one selected from the group consisting of glycerin, butylene glycol, propylene glycol, polyoxyethylene hardened castor oil, ethanol, triethanolamine Etc., and preservatives, colors, coloring agents, purified water, and the like can be included as needed.

The composition for external application for skin according to the present invention can be prepared in various forms such as lotion, essence, gel, emulsion, lotion, cream (underwater type, water type, multiphase), solution, suspension ), Capsules (soft capsules, hard capsules) having a coating such as anhydrous products (oil and glycol), gel, mask, pack, powder or gelatin.

The skin of the present invention includes not only the face but also the scalp and whole body. The composition for external application for skin which can be applied to such scalp includes shampoo, rinse, treatment, hair removal agent, etc., and a body cleanser And the like can be manufactured in various forms.

The method for preparing a composition for external application for skin containing a plant cell of mugwort mugwort, a culture of adventitious roots or an extract thereof according to the present invention is not limited to the above-mentioned preparation method, The method of the present invention may also be used to produce a composition for external application for skin containing mugwort plant cell of the present invention, a culture of adventitious roots or an extract thereof.

In particular, the composition for external application for skin may be prepared in the form of a general emulsified formulation and a solubilized formulation, by a known manufacturing method, in addition to the manufacturing method specifically disclosed in the present invention.

When the composition is prepared with a composition for external application for skin, examples of the cosmetic composition of the emulsified form include nutritional lotion, cream, essence and the like. It can also be prepared in the form of adjuvants which can be applied topically or systemically, which are conventionally used in the field of dermatology by containing a dermatologically acceptable medium or base.

In addition, suitable cosmetic formulations include, for example, solutions, gels, solid or kneaded anhydrous products, emulsions obtained by dispersing an oil phase in water, suspensions, microemulsions, microcapsules, microgranules or ionic forms (liposomes) May be provided in the form of a follicular dispersing agent of the type, cream, skin, lotion, powder, ointment, spray or conical stick. It can also be prepared in the form of a foam or an aerosol composition further containing a compressed propellant.

In addition, the composition for external application for skin of the present invention may further comprise at least one selected from the group consisting of fatty substances, organic solvents, solubilizers, thickeners and gelling agents, softening agents, antioxidants, suspending agents, stabilizers, foaming agents, As used herein means any emulsion or emulsion which is commonly used in emulsifying or emulsifying agents, fillers, sequestering and chelating agents, preservatives, vitamins, blockers, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic active agents, lipid vesicles or cosmetics Adjuvants commonly used in the cosmetics or dermatological fields, such as other ingredients. And, the above ingredients can be introduced in amounts commonly used in the field of dermatology.

The composition for external application for skin according to the present invention includes forms of functional cosmetics such as skin astringency, anti-inflammation, wound, wound healing, and anti-aging.

In the present invention, in the case of a pharmaceutical composition, it can function as a pharmaceutical composition for skin condition improvement as shown in the following examples.

Such a pharmaceutical composition may contain a "pharmaceutically acceptable carrier" in addition to an effective ingredient, a residual leaf mugwort plant cell, an adventitious root culture or an extract thereof. Such a carrier may be a diluent, a lubricant, a binder, a disintegrant, Stabilizers, and preservatives. The pharmaceutical composition may further comprise an additive. The additives may include flavoring agents, vitamins, and antioxidants. Examples of the diluent include lactose, dextrin, tapioca starch, corn starch, soybean oil, microcrystalline cellulose or mannitol as a carrier, magnesium stearate or talc as a lubricant, , And the binding agent may be polyvinylpyrrolidone or hydroxypropylcellulose. Examples of the disintegrant include carboxymethylcellulose calcium, sodium starch glycolate, polacrilin potassium, or crospovidone; examples of sweeteners include white sugar, fructose, sorbitol, or aspartame; stabilizers include sodium carboxymethylcellulose, Or xanthan gum, and the preservative may be methyl paraoxybenzoate, propyl p-hydroxybenzoate, or potassium sorbate.

The pharmaceutical composition may be formulated into conventional pharmaceutical formulations known in the art. The pharmaceutical composition may be formulated and administered in the form of an oral administration preparation, an injection preparation, a suppository, a transdermal preparation, and a dosage form. For example, the formulations may be formulated for oral administration, such as solutions, suspensions, powders, granules, tablets, capsules, pills, or expanses.

Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for illustrating the present invention and that the scope of the present invention is not construed as being limited by these embodiments.

Particularly, in the following examples, the efficacy of the mugwort plant cell, the adventitious root culture or the extract thereof was confirmed, but it will be obvious to those skilled in the art that the effect is also obtained with the culture itself, not with the extract.

1-1. In accordance with the present invention,

1.1 Derivation of Plant Cells of Leaf Mugwort Plants

Mugwort plants were sterilized in 70% ethanol and 0.5% sodium hypochlorite for 5 minutes and washed several times with sterilized water. Sucrose 30.0 g / L, Agar 5 to 10.0 g / L, p-Chlorophenoxyacetic acid (Mucin) were added to the MS basal medium (Murashige and Skoog 1962, Duchefa, Cat No. M0221) (4-CPA) 2 mg / L, Kinetin 0.1 mg, pH 5.5 to 6.0, preferably pH 5.7 to 5.8. After about 4 weeks, the leaves of Mugwort plant were induced from the cotyledon cut in the medium. The induced mugwort plant cells were proliferated by subculture at 2 - week intervals.

1.2 Induction of adventitious roots of mugwort plant

Mugwort plants were sterilized in 70% ethanol and 0.5% sodium hypochlorite for 5 minutes and washed several times with sterilized water. Sucrose 30.0 g / L, Agar 5 to 10.0 g / L, p-xylylenediamine, and the like were added to the MS basal medium (Murashige and Skoog 1962, Duchefa Co., Cat No. M0221) carefully with a tweezers and a sharp knife. The cells were subjected to MS solid medium containing pH of 5.5 to 6.0, preferably pH 5.7 to 5.8, containing 2 mg / L of chlorophenoxyacetic acid (4-CPA) and 0.1 mg of Zeatin. Adrenal ganglia were induced by culturing for 2 to 3 weeks. The induced mugwort adventitious root was propagated by subculture at 2 - week intervals.

1-2. Plant cells for increasing physiologically active substances, Adrenaline  Culture and mass production

Plant cells and adventitious roots of Aspergillus oryzae were transferred to MS medium containing 3% sucrose and 2 mg / L of p-chlorophenoxyacetic acid (4-CPA) and 0.1 mg of Kinetin at intervals of 2-3 weeks. And then cultured in a liquid medium of the same composition except agar using a balloon type bioreactor (Samsung Science) at a temperature of 25 ° C and an air supply of 0.1 vvm, and cultured at intervals of 14 days. Daily 30 μmolm ^-2 s ^-1 light intensity to the culture five parking 12h / 12h (light / dark) treatment, a UV-A treatment each day 4h, 250 μM Sikkim acid (Shikimic acid) and 250 μM jasmonic acid (Jasmonic acid) Were added to the MS medium and further cultured for 1 week and harvested.

1-3. Plant cells derived from the mugwort plant of the present invention, Adrenaline  Culture extract preparation

The proliferated leaves of Mugwort plant cells and adventitious roots were harvested, and the water was removed with a clean tissue and dried in a dryer at 60 ° C for 2 days. 100 g of the dried culture was placed in a container, and 10 L of purified water (or 10 L of 70% ethanol) was added thereto, followed by heating at 80 to 100 캜 for 8 to 48 hours in a hot water distiller to obtain a hot water extract. After the extraction, the extract was filtered with a mesh to remove the solids.

1-4. Analysis of HPLC components of culture extracts

Component analysis of the mugwort plant cell and adventitious root culture extracts was performed by HPLC. The analysis conditions were as follows.

division Analysis condition HPLC device type Waters 1525 Binary HPLC Pump Column type Gemini 5 C18 110 A (Phenomenex) Column Specification 250 * 4.60 mm, 5 micron Solvent conditions - Solvent A: Water (containing 0.1% TFA (Trifluoro acetic acid))
- Solvent B: Acetonitrile (containing 0.1% TFA (Trifluoro acetic acid)) wavelength 234 nm (UV lamp) Flow rate 1 ml / min

As a result of the analysis of the extract components of the plant cell culture, HPLC analysis peak results as shown in FIG. 2 were obtained, and the hydrothermal extract and ethanol extract of the adventitious root culture were found to have similar peak values. The extract obtained from the adult, not the mugwort, was dried in a drier at 60 ° C for 2 days, and then 100 g of the dried culture was placed in a container, and 10 L of purified water (or 10 L of 70% ethanol) The extract was heated at 80 ~ 100 ℃ for 8 ~ 48 hours in hot water distiller to obtain hot water extract, which was then filtered with a mesh to remove the solids, thereby preparing an extract of Mugwort. These adult extracts and the mugwort plant cell culture extracts showed different peak values.

Experimental Example  1: mugwort plant cell of the present invention and Adrenaline  Of culture extract COX -2 and iNOS  Anti-inflammatory effect test by active inhibition

Human keratinocyte cell line HaCaT (human keratinocyte) was cultured at 100 mm / 60.1 cm culture with Dulbecco's Modified Eagle's Medium (DMEM), 10% Fatal bovine serum (FBS) and 1% Antibiotic-Antimycotic (GIBCO, Cat. # 15240-062) and cultured in a dish at 37 ° C and 5% CO 2. When HaCaT was confluent at 90% confluence, cells were seeded at 1 × 10 ⁵ cells / dish in 100 mm / 60.1 cm ² culture dishes, cultured for 24 hours, and treated with 1% test substance concentration. After incubation for 4 hrs, the cells were lysed with 0.1% SDS, 1% NP40, 150 mM NaCl, 0.5% sodium deoxycholate, 50 mM Tris-Cl (pH 7.5) and protease inhibitors (Roche, Mannheim, Germany) And protein was quantitated by BCA assay. After transferring the separated proteins to the NC membrane, the membrane was blocked with blocking solution (5% skim milk in TBST (Tris-buffered saline with 0.1% Tween 20 ), Blocked for 30 minutes or more, washed with TBST, and reacted with primary antibody (COX-2, Abcam, Cat. # Ab-6665) solution overnight at 4 ° C. Then, the cells were washed 3 times for 10 minutes with TBST and reacted with primary antibody conjugated secondary antibody (COX-2: rabbit, iNOS: mouse) for 2 hours. The blot was analyzed by ECL solution kit (Amersham, UK).

As shown in FIG. 3, the results of the induction of tomato plant cells, green tea plant cells, and flowering plant cells in the manner as described in Example 1 did not show that COX-2 and iNOS gene expression were reduced. As shown in FIG. 4, the effects of plant cell and adventitious roots extract of Mugwort wormwood on COX-2 and iNOS protein expression were examined (using 5 uM hydrocortisone as a positive control), and hot water extraction and ethanol extraction , And that the expression of COX-2 and iNOS was decreased in both plant cell and adventitious root culture extracts.

Accordingly, the mugwort plant cell and the adventitious root culture extract according to the present invention have anti-inflammatory and inflammation-inhibiting effects, and the treatment of the attractant also increases the anti-inflammatory effect of the mugwort, which is not compatible with the plant cell culture of other species. Which is a unique incentive treatment.

Experimental Example  2: Wound healing assay Using Wound healing , Anti-aging efficacy test

Human keratinocyte cell line HaCaT (human keratinocyte) was incubated in 100 mm / 60.1 cm ² culture dishes at 37 ° C and 5 ° C with Dulbecco's Modified Eagle's Medium (DMEM), 10% Fatal bovine serum (FBS) and 1% Antibiotic-Antimycotic % CO2. When HaCaT was confluent at 90% confluence, cells were plated at 1.5 × 10 ⁵ cells / 12-well plate in 100 mm / 60.1 cm ² dish and cultured for 24 hours. After replacing with medium containing no FBS, And treated with 1% of the test substance, plant cells derived from the residual leaf mugwort plant, and the adventitious root culture extract, respectively. The cell image was photographed at 0 hour after material treatment and cultured at 37 ° C and 5% CO 2. After 18-20 h incubation, the medium was removed and incubated for 15 min at room temperature in a fixing solution (4% paraformaldehyde) and washed 3 times with PBS. Fixed cells were stored at 4 ° C for one month. The extent of the wound healing was measured by taking a picture under a microscope and using Image J program. The positive control group was 300 ng / ml EGF.

 Wound healing assay was used to evaluate the antioxidant effect by observing whether or not the cell proliferation and migration were promoted by the test substance. As a positive control, 300 ng / ml EGF was used.

As shown in FIG. 5 and FIG. 6, when the plant cell and the adventitious root culture extract derived from Leaf mugwort were respectively treated at a concentration of 1%, the plant cell and the adventitious root extract in both the hot water extraction and the ethanol extraction, It was confirmed that the healing area was increased by adhering to the skin cells and the floor. In addition, compared with the case where only some photogenerating agents were treated during the inducing agent treatment, it was found that the most effective wound healing effect was obtained when the four kinds of inducing agents as in Example 1 were all processed.

Experimental Example  3: skin convergence efficacy test

The principle of convergence is the phenomenon that the skin protein is contracted by binding with polymer flavonoids to form crosslinks. Convergence means basically wrinkling or retention, and since astringent agent has a property of binding to protein, it can generally judge the convergence effect depending on the degree of binding of hemoglobin protein to the extract. Such convergent action may be said to have the effect of forming an insoluble film on the surface of the skin and mucous membrane by external action and densifying the tissue to reduce the permeability of the cell membrane. For measurement of convergence effect, blood protein (hemoglobin, Sigma, Cat. # 08449) similar to skin protein was used. Each sample solution and hemoglobin solution (500ppm) were mixed in a ratio of 1: 1, shaken, and centrifuged at 1,500 rpm for 3 minutes, and the absorbance was measured at 576 nm. The measurement of the convergence effect was expressed by the absorbance reduction rate of the sample and the control group.

[Equation 1]

Concentration effect (%) = (1-absorbance of sample-added group / absorbance of no-addition group) x 100

Treatment concentration Measuring Convergence Effect
(Astringent activity test)
(% of control) Control group - 0 Tannic
acid - 37.9 Heat number
extraction Mugwort
Plant cell
Culture extract 0.5% 3.5 One % 16.2 5% 33.1 Mugwort
Adrenaline
Culture extract 0.5% 2.1 One % 11.3 5% 18.3 tomato
Plant cell
Culture extract 0.5% 0.5 One % 1.9 5% 3.3 Green tea
Plant cell
Culture extract 0.5% 0.6 One % 2.1 5% 3.8 Wind
Plant cell
Culture extract 0.5% 0.7 One % 2.6 5% 5.9 ethanol
extraction Mugwort
Plant cell
Culture extract 0.5% 4.5 One % 17.2 5% 35.1 Mugwort
Adrenaline
Culture extract 0.5% 3.1 One % 13.3 5% 25.3

As a result of measuring the convergence effect of plant cell and adventitious root culture extracts of Mugwort mugwort, it was confirmed that the concentration - dependent convergence effect was excellent in leaf - induced plant cell and adventitious root culture extracts as compared with the control group.

When only the photoperiod condition is processed,

Treatment concentration Measuring Convergence Effect
(Astringent activity test)
(% of control) Control group - 100 Heat number
extraction Mugwort
Plant cell
Culture extract 0.5% 100.1 One % 96.2 5% 93.1 Mugwort
Adrenaline
Culture extract 0.5% 99.5 One % 95.3 5% 98.3

As a result of measuring the convergence effect only at the condition of 12 o'clock (person) / 12 o'clock (dark), it was confirmed that the light condition alone did not affect the convergence effect.

As a result of measuring the convergence effect of plant cell and adventitious root culture extracts of Mugwort mugwort, it was confirmed that the concentration - dependent convergence effect was excellent in leaf - induced plant cell and adventitious root culture extracts as compared with the control group.

Experimental Example  4: B16F10 malanoma cell Using melanogenesis  Inhibition measurement

Melanin-producing cells, B16F10, were cultured in DMEM medium supplemented with 10% FBS and 1% antibiotics at 37 ° C, 5%, and CO2. B16F10 cells were suspended in DMEM medium containing 10% FBS at a concentration of 1.5 × 10 ³ cells / well in order to confirm the change of melanin production by the 1% residual mugwort plant cell and the adventitious root culture extract. Suspension cells (5 ml) are placed in a tissue culture flask and allowed to attach for 1 day. After adherence, a test sample was added and incubated at 37 ° C for 5 days in 5% CO2. The cultured B16F10 cells were washed with phosphate buffered saline (PBS) and trypsinized. After collection of cells in corning tube into the 1 × 10 ⁶ cell / per 1ml 1N NaOH solution and then dissolving the cells, by measuring the absorbance at 490nm with microplate reader it was determined melanogenesis inhibition.

In the present invention, in order to examine the effect of the plant cell and the adventitious root extract derived from the mugwort plant of the present invention on the melanin synthesis of the B16 / F10 melanoma cell, the total amount of melanin was measured after culturing for 3 days for each concentration of the test substance .

&Quot; (3) "

Inhibition of melanogenesis (%) = [1 - (Absample / Abcontrol)] 100

As a result, it was confirmed that melanin synthesis was decreased in both concentration and concentration of extracts of mugwort plant cell and adventitious roots cultured by hot water extraction and ethanol extraction.

Treatment concentration Melanin Contents
(% of control) Control group - 100 Heat number
extraction Mugwort
Plant cell
Culture extract 0.5% 95.1 One % 76.2 5% 83.1 Mugwort
Adrenaline
Culture extract 0.5% 91.5 One % 81.3 5% 78.3 tomato
Plant cell
Culture extract 0.5% 101.1 One % 98.3 5% 97.2 Green tea
Plant cell
Culture extract 0.5% 99.9 One % 97.1 5% 95.1 Wind
Plant cell
Culture extract 0.5% 99.6 One % 97.1 5% 96.2 ethanol
extraction Mugwort
Plant cell
Culture extract 0.5% 94.5 One % 77.2 5% 75.1 Mugwort
Adrenaline
Culture extract 0.5% 93.1 One % 73.3 5% 75.3

When only the photoperiod condition is processed,

Treatment concentration Melanin Contents
(% of control) Control group - 100 Heat number
extraction Mugwort
Plant cell
Culture extract 0.5% 100.1 One % 96.2 5% 93.1 Mugwort
Adrenaline
Culture extract 0.5% 99.5 One % 95.3 5% 98.3

As a result of measuring only the photoperiodic condition, it was confirmed that melanin synthesis was not reduced by treating only photoperiod of 12 o'clock (day) / 12 o'clock (cancer) condition.

Preparation of composition for external application for skin

Cosmetics of the emulsified form such as nutritional lotion, cream, essence, etc., and cosmetics of the solubilized form such as the softened longevity were prepared by the cosmetic product containing the extract of Aspergillus oryzae of the present invention as an active ingredient.

Production Example 2-1: Lotion

According to the following formulation, it was prepared according to the conventional lotion preparation method.

Raw material name Weight% (w / w) glycerin 5.0 Dipropylene glycol 3.0 Hyaluronic acid 0.5 Polyoxyethylene hardened castor oil 0.1 Polyethylene oleyl ethyl 0.1 ethanol 5.0 antiseptic 0.15 Beauty Suitable amount flash Suitable amount Leaf mugwort plant cell, adventitious root culture extract 2.0 Purified water to 100

Production Example 2-2: Essence

According to the following prescription, it was prepared according to a conventional method for producing essence.

Raw material name Weight% (w / w) Cetostearyl alcohol 1.0 Self emulsifying monostearic acid 1.0 Wax 0.5 Squalane 5.0 Isocetyl octanoate 3.0 Dimethylsiloxane 0.3 Sorbitan monostearate 0.5 Polyethylene glycol monostearate 8.0 glycerin 4.0 Propylene glycol 0.2 Carboxy polymer 0.22 Triethanolamine 0.25 antiseptic Suitable amount Spices Suitable amount flash Suitable amount Leaf mugwort plant cell, adventitious root culture extract 7.0 Purified water to 100

Production Example 2-3: Lotion

According to the following formulation, it was prepared according to a conventional lotion preparation method.

Raw material name Weight% (w / w) Cetostearyl alcohol 0.8 Self emulsifying monostearic acid 1.0 Wax 0.5 Stearic acid 0.5 Liquid paraffin 7.0 Squalane 5.0 Macadamia oil 3.0 Isocetyl octanoate 2.0 Dimethylsiloxane 0.3 Sorbitan monostearate 0.5 Polyethylene glycol monostearate 1.2 glycerin 4.0 Propylene glycol 4.0 Betaine 4.0 Carboxy polymer 0.12 Triethanolamine 0.15 antiseptic 0.25 Spices Suitable amount flash Suitable amount Leaf mugwort plant cell, adventitious root culture extract 5.0 Purified water to 100

Production Example 2-4: Cream

According to the following formulation, it was prepared according to a conventional cream production method.

Raw material name Weight% (w / w) Cetostearyl alcohol 3.0 Self emulsifying monostearic acid 1.5 Chin type monostearate 1.5 Wax 0.5 Liquid paraffin 8.0 Squalane 7.0 Isocetyl octanoate 4.0 Refined jojoba oil 4.0 Dimethylsiloxane 0.3 Sorbitan monostearate 1.0 Polyethylene glycol monostearate 1.2 glycerin 6.0 Propylene glycol 4.0 Betaine 4.0 Xanthan gum 0.06 Triethanolamine 0.10 antiseptic 0.25 Spices Suitable amount flash Suitable amount Leaf mugwort plant cell, adventitious root culture extract 7.0 Purified water to 100

Production Example 2-5: Gel

According to the following prescription, it was prepared according to a conventional gel preparation method.

Raw material name Weight% (w / w) glycerin 4.0 Propylene glycol 4.0 ethanol 10 Polyoxyethylene hardened castor oil 0.1 Carboxy polymer 0.30 Triethanolamine 0.30 antiseptic Suitable amount Spices Suitable amount flash Suitable amount Leaf mugwort plant cell, adventitious root culture extract 1.0 Purified water to 100

While the present invention has been particularly shown and described with reference to specific embodiments thereof, those skilled in the art will appreciate that such specific embodiments are merely preferred embodiments and that the scope of the invention is not limited thereby. It will be obvious. Accordingly, the actual scope of the present invention will be defined by the appended claims and their equivalents.

Claims (9)

Artemisia annua L. ), or an extract thereof.
[Claim 7] The composition for external application for skin according to claim 1, wherein the skin improving agent is for skin aging.
The composition for external application for skin according to claim 1, wherein the skin improving agent is a whitening agent.
Artemisia annua L. ) or a plant extract thereof, or an extract thereof.
Artemisia annua L. ) or a plant extract thereof, or an extract thereof.
Artemisia , including the following steps: annua L. ) plant cell or adventitious root culture or an extract thereof, comprising the steps of:
(a) separating leaves or stem tissues of Mugwort plant and culturing them into plant cells or adventitious roots; And
(b) preparing a composition for external application for skin containing the cultured plant cell of Mugwort mugwort or a culture of adventitious roots or an extract thereof.
The method of claim 6, wherein the step (a)
(i) isolating leaf or stem tissue of the mugwort plant and culturing the plant cell culture in a medium containing p-chlorophenoxyacetic acid and kinetin, or
(ii) isolating leaf or stem tissue of the mugwort plant and culturing it in a medium containing p-chlorophenoxyacetic acid and zeatin to obtain an adventitious culture;
≪ / RTI >
[7] The method of claim 6, wherein, in the step (a), the light / dark cycle is performed for 9 hours to 15 hours / 15 hours to 9 hours, UVA for 3 to 6 hours, Lt; RTI ID = 0.0 > 150uM < / RTI > to 400uM medium.
[7] The method according to claim 6, wherein the step (b) comprises: drying the cultured plant cells or the adventitious root culture of the mugwort plant extract obtained in step (a), pulverizing and mixing the resultant into purified water to prepare a composition, Mixing and then subjecting to ultrasonic extraction or hot water extraction to prepare a composition.

Images